Annual Report
2022

Our mission drives us – More life for people with cancer.

That’s why our work doesn’t stop when the research is done, or the discovery made. The burden of cancer is vast – on patients, their loved ones, and their healthcare providers – but so are our aspirations to redefine how cancer is treated.

More hope. More moments. More life.

Letter to Our Shareholders

“Our late-stage oncology pipeline has the potential to have a profound impact on patients’ lives. We are driven to develop and deliver more effective and safer treatment options for some of the world’s most difficult-to-treat blood cancers.”

Jean-Paul Kress, M.D., Chief Executive Officer

Read More

MORE
Science

Read More

MORE
Access

Read More

MORE
Community

Read More

Downloadable Versions

FullscreenFullscreen
CloseClose
Loading...